Welcome to our dedicated page for Orion S.A. SEC filings (Ticker: OEC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Orion S.A. filings document a Luxembourg-incorporated specialty chemicals issuer whose common shares trade on the New York Stock Exchange under OEC. Recent Form 8-K reports furnish earnings releases for its carbon black operations and disclose interim dividend declarations, annual general meeting logistics, board and officer changes, and related exhibit materials.
Proxy materials describe shareholder meeting procedures, voting matters and governance disclosures for Orion's société anonyme structure. The filing record also identifies the company's no-par-value common shares and provides formal updates tied to its Specialty Carbon Black and Rubber Carbon Black reporting themes, including operating results, pricing conditions and capital-return actions.
Orion S.A. (OEC) announced that its Board of Directors has declared an interim dividend of $0.0207 per common share, with an aggregate amount of approximately $1.2 million based on the current shares outstanding. The dividend is scheduled to be paid in the first quarter of 2027.
The interim dividend will be paid on January 19, 2027 to shareholders of record as of the close of business on December 11, 2026. The payment is subject to Luxembourg withholding tax at a rate of 15%, with possible exemptions or reductions in certain circumstances.
American Century entities reported passive ownership in Orion S.A. common shares. As of 06/30/2026, American Century ETF Trust reported beneficial ownership of 3,070,967 Orion common shares with 5.4% of the class, all with sole voting and dispositive power.
American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research each reported beneficial ownership of 3,202,288 Orion common shares, representing 5.7% of the class, all held with sole voting and sole dispositive power. Various underlying clients of American Century Investment Management have economic rights to dividends and sale proceeds associated with these shares, but no single client holds more than 5% of the class.
Orion S.A. reported Q2 2026 net sales of $500.9 million, up from $466.4 million, but net income declined to $1.8 million or $0.03 per share from $9.0 million. For the first six months, net sales were $960.4 million, yet results swung to a net loss of $8.1 million from $18.1 million profit a year earlier, with the effective tax rate reaching 505.0%.
Total Adjusted EBITDA fell to $58.2 million in Q2 and $104.3 million for the first half from $68.8 million and $135.0 million, driven by a sharp decline in the Rubber Carbon Black segment, where first-half Adjusted EBITDA dropped to $38.2 million from $89.7 million. The Specialty Carbon Black segment partly offset this, with Q2 Adjusted EBITDA rising to $39.0 million and first-half Adjusted EBITDA to $66.1 million.
Net cash provided by operating activities decreased to $14.9 million in the first half, and free cash flow was -$46.6 million as capital expenditures reached $61.5 million and Net working capital increased to $357.9 million. Orion reported total liquidity of $178.3 million (including $50.8 million of cash) and stated it remains in compliance with debt covenants, while highlighting heightened exposure to feedstock cost volatility and geopolitical risks affecting oil markets.
Orion S.A. reported second quarter 2026 results with net sales of $500.9 million, up from $466.4 million a year earlier. Net income was $1.8 million versus $9.0 million, while Adjusted EBITDA was $58.2 million, down from $68.8 million but described as a 26% sequential improvement.
The Specialty Carbon Black segment delivered strong recovery, with net sales of $184.8 million, a 17% increase, and Adjusted EBITDA of $39.0 million, up 96% year over year, supported by higher pricing, favorable mix and volumes. Rubber Carbon Black net sales were $316.1 million, up 3%, but Adjusted EBITDA fell 61% to $19.2 million due to lower contractual pricing, unfavorable mix and an intentional inventory draw.
Operating cash flow in the quarter was $27 million and free cash flow was $2 million, after $25 million of capital expenditures. Orion ended the quarter with net debt of $960.7 million, a net leverage ratio of 4.4x and liquidity of $178 million. Management reaffirmed 2026 Adjusted EBITDA guidance of $170–$210 million and raised full-year free cash flow guidance to a range from a $10 million outflow to $20 million inflow, noting a $43 million midpoint improvement versus prior guidance.
Hoogerbrugge Jacqueline reported acquisition or exercise transactions in this Form 4 filing.
Orion S.A. director Jacqueline Hoogerbrugge received an equity compensation grant of 19,150 restricted common shares on June 26, 2026. The grant was made at no cash cost per share and increased her direct holdings to 32,085 common shares.
The restricted shares will vest on the day prior to Orion S.A.'s 2027 Annual General Meeting of Shareholders, meaning she must remain in service through that date to fully earn the award.
LINDSEY MARY A reported acquisition or exercise transactions in this Form 4 filing.
Orion S.A. director Mary A. Lindsey received an equity compensation grant of 19,150 restricted common shares on June 26, 2026. The shares were granted at no cash cost and are subject to vesting conditions.
These restricted shares vest on the day prior to Orion’s 2027 Annual General Meeting of Shareholders. Following this grant, Lindsey directly holds a total of 75,039 common shares, reflecting a routine board-level stock award rather than an open-market share purchase or sale.
PAIK YI HYON reported acquisition or exercise transactions in this Form 4 filing.
Orion S.A. director Paik Yi Hyon received a grant of 19,150 restricted common shares on June 26, 2026. The grant was made at a price of $0.00 per share as an award, not an open-market purchase.
These restricted shares will vest on the day before Orion S.A.'s 2027 Annual General Meeting of Shareholders. Following this grant, Paik Yi Hyon directly owns 65,039 common shares of Orion S.A., according to the filing.
HUCK PAUL E reported acquisition or exercise transactions in this Form 4 filing.
Orion S.A. director Paul E. Huck received a grant of 19,150 restricted common shares on June 26, 2026 as equity compensation. The shares were granted at no cash cost per share and increase his direct holdings to 103,357 common shares. These restricted shares vest on the day prior to Orion S.A.’s 2027 Annual General Meeting of Shareholders, meaning he must remain in service until then for full vesting.
Miraton Didier reported acquisition or exercise transactions in this Form 4 filing.
Orion S.A. director Miraton Didier received a grant of 19,150 restricted common shares on June 26, 2026. The award was granted at no cash cost per share as part of his compensation.
These restricted shares vest on the day before Orion S.A.'s 2027 Annual General Meeting of Shareholders, bringing his direct holdings to 73,357 common shares.
GALVIN KERRY A reported acquisition or exercise transactions in this Form 4 filing.
Orion S.A. director Kerry A. Galvin received a grant of 19,150 restricted common shares on June 26, 2026 as equity compensation. These restricted shares vest on the day before the company’s 2027 Annual General Meeting of Shareholders, bringing Galvin’s direct holdings to 84,753 common shares after the grant.